Skip to Content

Fluticasone/Salmeterol Inhalation Aerosol (Advair HFA)

Last Updated: October 14, 2013
Status: Resolved

Products Affected - Description

Fluticasone/Salmeterol Inhalation Aerosol

Reason for the Shortage

  • GlaxoSmithKline recalled several lots of Advair HFA 45/21 inhalers in December 2012 due to particle sizes outside of specification.
  • This shortage does not affect Advair Diskus inhalation powder formulations.
  • This shortage does not affect Flovent (fluticasone) or Serevent (salmeterol) single-agent products.

Available Products

Advair HFA Inhalation Aerosol, GlaxoSmithKline

Fluticasone 45 mcg/Salmeterol 21 mcg, 12 gram (120 doses) (NDC 00173-0715-20)
Fluticasone 45 mcg/Salmeterol 21 mcg, 8 gram (60 doses) (NDC 00173-0715-22)
Fluticasone 115 mcg/Salmeterol 21 mcg, 8 gram (60 doses) (NDC 00173-0716-22)
Fluticasone 115 mcg/Salmeterol 21 mcg, 12 gram (120 doses) (NDC 00173-0716-20)
Fluticasone 230 mcg/Salmeterol 21 mcg, 12 gram (120 doses) (NDC 00173-0717-20)
Fluticasone 230 mcg/Salmeterol 21 mcg, 8 gram (60 doses) (NDC 00173-0717-22)

Estimated Resupply Dates

All presentations are currently available.

Related Shortages

Updated

October 14, 2013; September 30, 2013; August 27, 2013; July 25, 2013; May 28, 2013; May 17, 2013; April 22, 2013, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide